Nightingale Health Oyj Stock Forecast for 2023 - 2025 - 2030
Updated on 03/28/2024
Nightingale Health Oyj Stock Forecast and Price Target
If Nightingale Health Oyj's stock price reached the average yearlong target of 1.25€ given by well-known analysts in recent months, there would be a potential upside of approximately 17.92% from its last closing price in March, 2024. This potential increase is based on a high estimate of 1.25€ and a low estimate of 1.25€. Although you may not be interested in HEALTH stock, you should still be aware of its competitors.
17.92% Upside
Nightingale Health Oyj Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, Nightingale Health Oyj's Price has grown by 100.00%, from 0.00€ to 0.00€. For the next year, analysts are expecting Fair Value to reach 0.00€ – an increase of 100.00%. Over the next six years, experts predict that Fair Value will grow by 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
LH Stock Forecast | Laboratory Corp of America Hol... | Outperform |
11
|
$218.53 | Buy/Sell | $241.28 | 11.20% |
DGX Stock Forecast | Quest Diagnostics | Outperform |
10
|
$129.43 | Buy/Sell | $141.17 | 9.94% |
300676 Stock Forecast | BGI Genomics | - |
17
|
¥43.24 | Buy/Sell | ¥0.00 | -100.00% |
MYGN Stock Forecast | Myriad Genetics | Hold |
6
|
$22.58 | Buy/Sell | $22.08 | 10.72% |
CEVI Stock Forecast | CellaVision AB (publ) | Outperform |
16
|
kr228.00 | Buy/Sell | kr191.75 | 6.36% |
Nightingale Health Oyj Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Nightingale Health Oyj's Revenue has grown by 100.96%, from 2.08€M to 4.18€M. According to 0 prominent analysts, Nightingale Health Oyj's Revenue will fall by 33.15% in the next year, reaching 2.79€M. By 2030, professionals believe that Nightingale Health Oyj's Revenue will decrease by 29.61%, reaching 2.94€M – a concerning trend for the company.
Nightingale Health Oyj EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Nightingale Health Oyj's EBITDA has grown by 210.37%, rising from -4.82€M to -14.96€M. In the next year, 0 analysts estimate that Nightingale Health Oyj's EBITDA will decrease by 34.69%, reaching -9.77€M. According to professional forecasts, in 2030, Nightingale Health Oyj's EBITDA will decrease by 31.03%, reaching -10.32€M.
Nightingale Health Oyj EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Nightingale Health Oyj's EBIT has grown, rising from -5.28€M to -18.49€M – a growth of 250.19%. According to 0 analysts, Nightingale Health Oyj's EBIT will fall by 37.99% in the next year, reaching -11.47€M. Professionals believe that By 2030, Nightingale Health Oyj's EBIT will fall to -12.36€M – a 33.16% decrease from its current value.
Nightingale Health Oyj EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, Nightingale Health Oyj's EPS has grown by 100.00%, from -0.27€ to 0.00€. For the next year, analysts are expecting EPS to reach 0.00€ – an increase of 100.00%. Over the next six years, experts predict that EPS will grow by 100.00%.